Urologisk kirurgi

Surveillance and follow-up of early prostate cancer

Ahlberg, Mats Steinholtz

2024

• Ladda ner fulltext (pdf) av Surveillance and follow-up of early prostate cancer

Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years

Acosta Ruiz, Vanessa; Dahlman, Pär; Brekkan, Einar; Lönnemark, Maria et al.

Ingår i Acta Radiologica, s. 294-301, 2024

• DOI för Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years
• Ladda ner fulltext (pdf) av Microwave ablation of 105 T1 renal tumors: technique efficacy with a mean follow-up of two years

Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

Westerberg, Marcus; Irenaeus, Sandra; Garmo, Hans; Stattin, Pär et al.

Ingår i PLOS ONE, 2024

• DOI för Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study
• Ladda ner fulltext (pdf) av Development and validation of a multi-dimensional diagnosis-based comorbidity index that improves prediction of death in men with prostate cancer: Nationwide, population-based register study

The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Westerberg, Marcus; Holmberg, Lars; Ekbom, Anders; Metcalfe, Chris et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 503-511, 2024

• DOI för The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial
• Ladda ner fulltext (pdf) av The role of endoscopist adenoma detection rate in in sex differences in colonoscopy findings: cross-sectional analysis of the SCREESCO randomized controlled trial

Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Stattin, Pär; Westerberg, Marcus; Lissbrant, Ingela Franck; Eriksson, Marie Hjälm et al.

Ingår i Clinical Genitourinary Cancer, s. 1070-107000000000, 2023

• DOI för Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden
• Ladda ner fulltext (pdf) av Real World Outcomes in Patients With Metastatic, Castration-Resistant Prostate Cancer Treated With Radium-223 in Routine Clinical Practice in Sweden

Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

Westerberg, Marcus; Beckmann, Kerri; Gedeborg, Rolf; Irenaeus, Sandra et al.

Ingår i Journal of Clinical Epidemiology, s. 22-30, 2023

• DOI för Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.
• Ladda ner fulltext (pdf) av Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidence.

How to model temporal changes in epidemiological data: Treatment trajectories in men with prostate cancer

Ventimiglia, Eugenio

2023

• Ladda ner fulltext (pdf) av How to model temporal changes in epidemiological data: Treatment trajectories in men with prostate cancer

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Mezheyeuski, Artur; Backman, Max; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Ingår i EBioMedicine, 2023

• DOI för An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
• Ladda ner fulltext (pdf) av An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study

Bergengren, Oskar; Belozerov, Alexej; Bill-Axelson, Anna; Garmo, Hans et al.

Ingår i European Journal of Surgical Oncology, s. 868-874, 2023

• DOI för Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study
• Ladda ner fulltext (pdf) av Short term outcomes after robot assisted and open cystectomy- A nation-wide population-based study

Estimation in discrete time coarsened multivariate longitudinal models

Westerberg, Marcus

Ingår i Statistical Methods in Medical Research, s. 806-819, 2023

• DOI för Estimation in discrete time coarsened multivariate longitudinal models
• Ladda ner fulltext (pdf) av Estimation in discrete time coarsened multivariate longitudinal models

Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Lin, E.; Garmo, Hans; Hagström, Emil; Van Hemelrijck, Mieke et al.

Ingår i British Journal of Cancer, s. 814-824, 2023

• DOI för Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden
• Ladda ner fulltext (pdf) av Association between atherogenic lipids and GnRH agonists for prostate cancer in men with T2DM: a nationwide, population-based cohort study in Sweden

Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Sun, Ming; Fritz, Josef; Häggström, Christel; Bjørge, Tone et al.

Ingår i Journal of the National Cancer Institute, s. 456-467, 2023

• DOI för Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study
• Ladda ner fulltext (pdf) av Metabolically (un)healthy obesity and risk of obesity-related cancers: a pooled study

Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Jarvholm, Bengt et al.

Ingår i European Urology, s. 422-431, 2023

• DOI för Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study
• Ladda ner fulltext (pdf) av Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study

Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Sekiguchi, Masau; Westerberg, Marcus; Ekbom, Anders; Hultcrantz, Rolf et al.

Ingår i Gastroenterology, s. 293-2950000, 2023

• DOI för Endoscopist Characteristics and Polyp Detection in Colonoscopy: Cross-Sectional Analyses of Screening of Swedish Colons

Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i JNCI CANCER SPECTRUM, 2023

• DOI för Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study
• Ladda ner fulltext (pdf) av Risks of alcohol and drug use disorders in prostate cancer survivors: a national cohort study

2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review

Bergengren, Oskar; Pekala, Kelly R.; Matsoukas, Konstantina; Fainberg, Jonathan et al.

Ingår i European Urology, s. 191-206, 2023

• DOI för 2022 Update on Prostate Cancer Epidemiology and Risk Factors-A Systematic Review

Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Kerzeli, Iliana Kyriaki; Kostakis, Alexandros; Türker, Polat; Malmström, Per-Uno et al.

Ingår i BMC Cancer, 2023

• DOI för Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer
• Ladda ner fulltext (pdf) av Elevated levels of MMP12 sourced from macrophages are associated with poor prognosis in urothelial bladder cancer

Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

Röbeck, Pontus; Franzén, Bo; Cantera-Ahlman, Rafaele; Dragomir, Anca et al.

Ingår i Cytopathology, s. 286-294, 2023

• DOI för Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade
• Ladda ner fulltext (pdf) av Multiplex protein analysis and ensemble machine learning methods of fine needle aspirates from prostate cancer patients reveal potential diagnostic signatures associated with tumour grade

Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Wilberg Orrason, Andri; Styrke, Johan; Garmo, Hans; Stattin, Pär

Ingår i BJU International, s. 486-493, 2023

• DOI för Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden
• Ladda ner fulltext (pdf) av Evidence of cancer progression as the cause of death in men with prostate cancer in Sweden

Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Crump, Casey; Stattin, Pär; Brooks, James D.; Sundquist, Jan et al.

Ingår i European Urology, s. 263-272, 2023

• DOI för Long-term Risks of Depression and Suicide Among Men with Prostate Cancer: A National Cohort Study

Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies

Feng, Shuo; Lin, E.; Cowling, Benjamin J.

Ingår i LANCET REGIONAL HEALTH-AMERICAS, 2023

• DOI för Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies
• Ladda ner fulltext (pdf) av Number needed to vaccinate for COVID-19 booster doses: a valuable metric to inform vaccination strategies

P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer

Röbeck, Pontus; Xu, Lidi; Ahmed, Dilruba; Dragomir, Anca et al.

Ingår i The Prostate, s. 831-839, 2023

• DOI för P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer
• Ladda ner fulltext (pdf) av P-score in preoperative biopsies accurately predicts P-score in final pathology at radical prostatectomy in patients with localized prostate cancer

Design considerations for observational studies of drugs for advanced cancer

Garcia-Albeniz, Xabier; Stattin, Pär; Westerberg, Marcus; Weinrib, Rachel et al.

Ingår i Pharmacoepidemiology and Drug Safety, s. 812-815, 2023

• DOI för Design considerations for observational studies of drugs for advanced cancer
• Ladda ner fulltext (pdf) av Design considerations for observational studies of drugs for advanced cancer

Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

George, Gincy; Garmo, Hans; Adolfsson, Jan; Elf, Kristin et al.

Ingår i Journal of Oncology, s. 9527920, 2023

• DOI för Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden.

Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Robinson, David; Abdulkareem, Rafid; Nasrollah, Delshad; Ljung, Anders et al.

Ingår i JAMA Network Open, 2023

• DOI för Frequency of Biopsy and Tumor Grade Before vs After Introduction of Prostate Magnetic Resonance Imaging.

Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Corsini, Christian; Garmo, Hans; Wilberg Orrason, Andri; Gedeborg, Rolf et al.

Ingår i JAMA Network Open, 2023

• DOI för Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy
• Ladda ner fulltext (pdf) av Survival Trend in Individuals With De Novo Metastatic Prostate Cancer After the Introduction of Doublet Therapy

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Ahlberg, Mats Steinholtz; Garmo, Hans; Holmberg, Lars; Bill-Axelson, Anna

Ingår i European Urology Open Science, s. 166-173, 2023

• DOI för Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
• Ladda ner fulltext (pdf) av Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Active surveillance should be considered for select men with Grade Group 2 prostate cancer

Pekala, Kelly R.; Bergengren, Oskar; Eastham, James A.; Carlsson, Sigrid V.

Ingår i BMC Urology, 2023

• DOI för Active surveillance should be considered for select men with Grade Group 2 prostate cancer
• Ladda ner fulltext (pdf) av Active surveillance should be considered for select men with Grade Group 2 prostate cancer

Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Jochems, Sylvia H. J.; Fritz, Josef; Häggström, Christel; Stattin, Pär et al.

Ingår i Cancer Medicine, s. 13732-13744, 2023

• DOI för Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study
• Ladda ner fulltext (pdf) av Prediagnostic markers of insulin resistance and prostate cancer risk and death: A pooled study

Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Stattin, Pär

Ingår i Scandinavian journal of urology, s. 1-1, 2023

• DOI för Thanks and good bye Taylor & Francis, authors and readers see you at Scand J Urol's new website!

Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

Bonde, Tiago M.; Garmo, Hans; Stattin, Pär; Nilsson, Per et al.

Ingår i Acta Oncologica, s. 1815-1821, 2023

• DOI för Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists
• Ladda ner fulltext (pdf) av Risk of prostate cancer death after radical radiotherapy with neoadjuvant and adjuvant therapy with bicalutamide or gonadotropin-releasing hormone agonists

The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019

Wang, Eugen Y-H; Hagberg, Oskar; Malmström, Per-Uno

Ingår i PLOS ONE, 2023

• DOI för The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019
• Ladda ner fulltext (pdf) av The association between BCG treatment in patients with bladder cancer and subsequent risk of developing Alzheimer and other dementia.: -A Swedish nationwide cohort study from 1997 to 2019

Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Shore, Richard; Zhang, Ji; Ye, Weimin; Stattin, Pär et al.

Ingår i Cancer Causes and Control, s. 949-961, 2023

• DOI för Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.
• Ladda ner fulltext (pdf) av Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study.

Welcome to the new Scandinavian Journal of Urology!

Stattin, Pär

Ingår i Scandinavian journal of urology, 2023

• DOI för Welcome to the new Scandinavian Journal of Urology!
• Ladda ner fulltext (pdf) av Welcome to the new Scandinavian Journal of Urology!

Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Gedeborg, Rolf; Sandin, Fredrik; Thellenberg-Karlsson, Camilla; Styrke, Johan et al.

Ingår i Scandinavian journal of urology, s. 93-100, 2023

• DOI för Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden
• Ladda ner fulltext (pdf) av Uptake of doublet therapy for de novo metastatic castration sensitive prostate cancer: a population-based drug utilisation study in Sweden

Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up

Malmström, Per-Uno; Gårdmark, Truls

Ingår i Scandinavian journal of urology, s. 109-114, 2023

• DOI för Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up
• Ladda ner fulltext (pdf) av Abandoning testing for asymptomatic microscopic haematuria in Sweden - a long-term follow-up

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Watts, Eleanor L.; Perez-Cornago, Aurora; Fensom, Georgina K.; Smith-Byrne, Karl et al.

Ingår i International Journal of Epidemiology, s. 71-86, 2023

• DOI för Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
• Ladda ner fulltext (pdf) av Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis

Re: An Integrated Multi-Omics Analysis Identifies Prognostic Molecular Subtypes of Non-Muscle Invasive Bladder Cancer: Editorial Comment

Lindskrog, S. , V; Prip, F.; Lamy, P.; Taber, A. et al.

Ingår i Journal of Urology, s. 733-733, 2022

Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

Gedeborg, Rolf; Lindhagen, Lars; Loeb, Stacy; Styrke, Johan et al.

Ingår i Scandinavian journal of urology, s. 104-111, 2022

• DOI för Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer
• Ladda ner fulltext (pdf) av Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancer

A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality

Söderdahl, Fabian; Xu, Li-Di; Bring, Johan; Häggman, Michael

Ingår i Research and Reports in Urology, s. 203-217, 2022

• DOI för A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality
• Ladda ner fulltext (pdf) av A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific Mortality

Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Jochems, Sylvia H. J.; Häggström, Christel; Stattin, Pär; Järvholm, Bengt et al.

Ingår i Cancer Epidemiology, Biomarkers and Prevention, s. 1483-1491, 2022

• DOI för Association of Blood Pressure with Prostate Cancer Risk by Disease Severity and Prostate Cancer Death: A Pooled Cohort Study

Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Lycken, Magdalena; Bergengren, Oskar; Drevin, Linda; Garmo, Hans et al.

Ingår i European Urology Open Science, s. 81-87, 2022

• DOI för Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths
• Ladda ner fulltext (pdf) av Changes in Characteristics of Men with Lethal Prostate Cancer During the Past 25 Years: Description of Population-based Deaths

Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Bonde, Tiago M.; Westerberg, Marcus; Aly, Markus; Eklund, Martin et al.

Ingår i Scandinavian journal of urology, s. 169-175, 2022

• DOI för Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists
• Ladda ner fulltext (pdf) av Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists

Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Gedeborg, Rolf; Garmo, Hans; Thellenberg-Karlsson, Camilla; Fallara, Giuseppe et al.

Ingår i Acta Oncologica, s. 328-332, 2022

• DOI för Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study

Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Alverbratt, Charlotte; Vikman, Hanna; Eriksson, Marie Hjalm; Stattin, Pär et al.

Ingår i Scandinavian journal of urology, s. 95-101, 2022

• DOI för Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records
• Ladda ner fulltext (pdf) av Time difference in retrieving clinical information in Patient-overview Prostate Cancer compared to electronic health records

Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors

Häggman, Michael; Dahlman, Par; Ahlberg, Mats; Liss, Per et al.

Ingår i Acta Radiologica Open, 2022

• DOI för Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors
• Ladda ner fulltext (pdf) av Bi-parametric MRI/TRUS fusion targeted repeat biopsy after systematic 10-12 core TRUS-guided biopsy reveals more significant prostate cancer especially in anteriorly located tumors

Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Braide, Karin; Kindblom, Jon; Karlsson, Camilla Thellenberg; Stattin, Pär et al.

Ingår i BJU International, s. 799-808, 2022

• DOI för Risk of severe late toxicity after radiotherapy following radical prostatectomy - a nationwide study

Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden

Godtman, Rebecka Arnsrud; Persson, Erik; Bergengren, Oskar; Carlsson, Stefan et al.

Ingår i Scandinavian journal of urology, s. 343-350, 2022

• DOI för Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden
• Ladda ner fulltext (pdf) av Surgeon volume and patient-reported urinary incontinence after radical prostatectomy: Population-based register study in Sweden

Watch out for sticky diagnosis bias in older men with prostate cancer: Editorial comment to “Evidence of overestimating prostate cancer mortality in Estonia: a population-based study by Innos K et al.”

Bergengren, Oskar; Westerberg, Marcus

Ingår i Scandinavian journal of urology, s. 365-366, 2022

• DOI för Watch out for sticky diagnosis bias in older men with prostate cancer: Editorial comment to “Evidence of overestimating prostate cancer mortality in Estonia: a population-based study by Innos K et al.”

Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re: Sylvia HJ Jochems, Josef Fritz, Christel Haggstrom, Bengt Jarvholm, Par Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers

Jochems, Sylvia H. J.; Stattin, Pär; Stocks, Tanja

Ingår i European Urology, 2022

• DOI för Reply to Paulius Bosas, Gintaras Zaleskis, and Dainius Characiejus's Letter to the Editor re: Sylvia HJ Jochems, Josef Fritz, Christel Haggstrom, Bengt Jarvholm, Par Stattin, Tanja Stocks. Smoking and Risk of Prostate Cancer and Prostate Cancer Death: A Pooled Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.033. Therapeutic Monitoring in Prostate Cancer Should Involve a Cotinine Test in Current Smokers